Caricamento...
A Novel Approach to Screening for New Neuroprotective Compounds for the Treatment of Stroke
Despite the significant advances that have been made in understanding the pathophysiology of cerebral ischemia on the cellular and molecular level, only one drug, the thrombolytic tissue plasminogen activator (rt-PA), is approved by the FDA for use in patients with acute ischemic stroke. Therefore,...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2007
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2111291/ https://ncbi.nlm.nih.gov/pubmed/17765210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2007.07.061 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|